EMCDDA Home
  • EN
Search

Table TDI-106. New clients entering outpatient treatment by primary drug and age at first use, 2011 or most recent year available

Part (v) New hypnotics and sedatives outpatient clients by country and age at first use

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium1100101047478
Bulgaria00000000000
Czech Republic00003001426
Denmark11141110221223
Germany1438403428191936228155383
Estonia:::::::::::
Ireland12381745310801191
Greece4922110221324
Spain13613363615551347150476580
France61913131381369123114
Italy20254988160321381139
Cyprus02121001707
Latvia313212030121123
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary1713225526026
Malta:::::::::::
Netherlands1135382421101023172220392
Austria31034110022325
Poland4:1212::::::
Portugal51041411012012
Romania00000000000
Slovenia:::1:::::1:
Slovakia0421011110010
Finland151000007512
Sweden1422169353981081
United Kingdom62853201641241101058416413561801536
Croatia3431121::5:
Turkey:::::::::::
Norway:::::::::::
Total39468742529526222617635327967723562
 

Notes:

: Indicates no data are available

(1) Data are from 2010.

(2) In 2011 around 27% of all clients and 32% of new clients were registered as not known / missing for the primary drug category. Caution should be made when comparing data over time.

(3) In 2010 Latvia submitted a new dataset with a more precise TDI EMCDDA definition. Caution should be made when comparing data with previous years.

(4) Data are from 2010. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data.

(5) In 2010 came into implementation a new national information system implying methodological changes particularly in the registration criteria. Caution should be made when comparing 2010 data with previous years.

(6) Data are from 1st of April 2010 to 31st March 2011.

For more information relative to the treatment centre type, please see Table TDI-7.

See also Table TDI-11 part(i), part(ii)

‘General notes for interpreting data'’ on the Explanatory notes and help page.

Source:

Reitox national reports 2012- Table TDI Outpatient Treatment Centres

About the EMCDDA

The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU's decentralised agencies. Read more >>

Contact us

EMCDDA
Praça Europa 1, Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11

More contact options >>

Page last updated: Friday, 26 April 2013